Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study

Area of Science:

• Urology
• Rheumatology
• Preventive Medicine

Background:

• Asymptomatic hyperuricemia, defined by elevated serum urate levels, is common.
• The clinical significance and management of asymptomatic hyperuricemia remain debated.
• Quantifying the risk of gouty arthritis in individuals with elevated urate levels is crucial.

Purpose of the Study:

• To determine the incidence of gouty arthritis in men with asymptomatic hyperuricemia.
• To identify predictors of gouty arthritis in a healthy male cohort.
• To evaluate the association between hyperuricemia and renal function.

Main Methods:

• Prospective observational study of 2,046 healthy men over 14.9 years.
• Serial measurements of serum urate levels and clinical examinations.
• Proportional hazards modeling to identify risk factors for gouty arthritis.

Main Results:

• Annual incidence of gouty arthritis was 4.9% for urate levels ≥9 mg/dl, versus 0.5% for 7.0–8.9 mg/dl and 0.1% for <7.0 mg/dl.
• Cumulative incidence reached 22% after five years for levels ≥9 mg/dl.
• Serum urate level was the strongest predictor of gout, overshadowing age, BMI, hypertension, cholesterol, and alcohol intake; no significant renal deterioration was observed.

Conclusions:

• Asymptomatic hyperuricemia, particularly levels ≥9 mg/dl, is a strong predictor of future gouty arthritis.
• Conservative management strategies for asymptomatic hyperuricemia are supported by these findings.
• Hyperuricemia did not show evidence of causing renal deterioration in this cohort.